drugset / Trial / NCT01472055

Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation

NCT01472055 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to analysis of the pharmacokinetics of fludarabine for hematopoietic stem cell transplantation in pediatric patients.

Timeline

Start
2011-10
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Fludarabine Small molecule 40 mg/m2 Intravenous